Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-22-002761
Filing Date
2022-11-14
Accepted
2022-11-14 16:21:47
Documents
53
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 10-Q SEC FILING tpia-20220930.htm   iXBRL 10-Q 452099
2 CERTIFICATION tpia_ex31z1.htm EX-31.1 8506
3 CERTIFICATION tpia_ex32z1.htm EX-32.1 4446
  Complete submission text file 0001096906-22-002761.txt   2459951

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpia-20220930_cal.xml EX-101.CAL 19287
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20220930_def.xml EX-101.DEF 67403
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20220930_lab.xml EX-101.LAB 151038
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20220930_pre.xml EX-101.PRE 136780
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20220930.xsd EX-101.SCH 29053
47 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20220930_htm.xml XML 287584
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56022 | Film No.: 221385893
SIC: 5141 Wholesale-Groceries, General Line